Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful cancer research happening across departments, including Ludwig.

New view of a transcriptional regulator driving melanoma proliferation


A study from Professor Colin Goding’s group finds an unexpected mechanism controlling growth vs senescence in cancer.

The point of no return: chromatin enforces cell fate decisions


Interactions between transcription factors and the chromatin environment provide barriers controlling cell differentiation, according to research by Professor Yang Shi and colleagues.

Vacancy - Postdoctoral Research Scientist

Constantinescu Jobs Kriaucionis

Grade 7: £33,309 - £40,927 (with a discretionary range to £44,706 per annum)

Developmental origins of inherited cancers bearing mutations in the oxygen-sensing pathway


Dr Tammie Bishop’s and Professor Sir Peter Ratcliffe’s groups shed light on the developmental origins of inherited cancers with mutations in the HIF pathway.

NDM prize studentships - apply now for October 2022 entry

Boccellato Moura Alves Schuster-Böckler Song

Ludwig Oxford is currently recruiting exceptional students for fully funded four-year NDM prize DPhil studentships commencing in October 2022.

Regulating the regulator


Mads Gyrd-Hansen’s group investigates how the deubiquitinase CYLD, which moderates innate immune responses, is itself regulated.

DPhil in Cancer Science Programme - apply now for October 2022 entry

Boccellato Kriaucionis Lu Song

The University of Oxford is recruiting its third intake to study for a DPhil in Cancer Science commencing in October 2022.

Ludwig Oxford welcomes new leadership fellow Dr. Parinaz Mehdipour


Our new Leadership Fellow launches a research group in cancer epigenetics and epitranscriptomics.

Turing Fellowship for Ludwig Oxford’s Benjamin Schuster-Böckler


Dr Benjamin Schuster-Böckler will join the Turing network for 2021-2022 to further his research in cancer big data.

Investigating drug resistance in melanoma


Ludwig Oxford’s Professor Colin Goding and Sao Paulo’s Professor Silvya Stuchi Maria-Engler show that TOP1 is involved in melanoma progression and adaptive resistance to treatment.

Liver immunologist Professor Ellie Barnes joins Ludwig Oxford as Adjunct Scholar


Ludwig Oxford welcomes Ellie Barnes to our community, which she has joined as a Ludwig Adjunct Scholar.

Vaccine for treating cancer made possible using Oxford COVID vaccine technology

Van den Eynde

A new publication from Benoit Van den Eynde's group has shown that a viral vector cancer vaccine generates effective anti-tumour immune responses and, in combination with immunotherapy, decreases tumour size and increases survival rates in mouse models.

Ludwig Oxford student presents at TEDx Youth event

Boccellato Public Engagement

Claudia Zagami from the Boccellato lab was selected to give a talk on 3D tissue models for studying disease.

UNIQ summer school 2021

Kriaucionis Lu Public Engagement Van den Eynde

Three Ludwig Oxford volunteers participate at the 2021 Oncology UNIQ summer school

Ludwig Oxford and Oxford University welcome Professor Stefan Constantinescu


Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.

Understanding the role of BRN2 in melanoma


A study from Professor Colin Goding’s group gives insight into the function of the BRN2 transcription factor in promoting melanoma initiation and metastasis.

AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus

Lu Rittscher

Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.

Combination treatment approach for acute myeloid leukaemia


Professor Yang Shi’s group demonstrates that combining drugs targeting epigenetic and metabolic pathways can overcome the arrest of white blood cell differentiation in this blood cancer.

Reporter assay to identify dormant cells


Professor Colin Goding’s lab collaborate with colleagues in Germany to develop a new method to measure stem cell dormancy.

Load More